Page 48 - Sputnik News Today

Cebu City to use Sputnik V

Keventer Agro Expands Board, Inducts Two New Independent Directors Two notorious drug peddlers held in Kupwara, contraband recovered 2105 people fined, 24 held for flouting COVID rules in Kashmir Seven people injured in mysterious blast in Pulwama 823 new Covid cases in Manipur Santhal Pargana Commissioner orders fresh probe into recovery of illegal liqour worth Rs 1 cr Earth Anthem calls for reimagining our relationship with Earth and each other Vaccination to 65,000 within June: CM PS Tamang ...

Uniindia: Bengaluru, Jun 6 (UNI) Manipal Hospitals, India’s second largest multi-speciality hospital chain, announced collaboration with Dr Reddy’s Laboratories (”Dr Reddy’s”) to add the Sputnik V vaccine pilot in its existing vaccine portfolio that comprises of Covishield and Covaxin.

India continues to record the highest number of new cases in the world with 1,37,947 average daily infections on June 4.

Manipal Hospitals to offer Sputnik V later this month SECTIONS Last Updated: Jun 06, 2021, 01:08 PM IST Share Synopsis The Russian vaccine is currently under pilot at Manipal, and the hospital chain hopes to roll it out for the public after the second week of this month. Reuters The hospital, he said, has worked with Dr. Reddy’s to create the necessary infrastructure to maintain the Sputnik V vaccine. Bengaluru-headquartered Manipal Hospitals has tied-up with Dr. Reddy’s Laboratories to add...

A company in Malta has expressed interest in supplying 60 million doses of Russia's COVID-19 vaccine 'Sputnik V' to Haryana, the state government said.

Uniindia: Chandigarh, Jun 6 (UNI) Haryana Health Minister Anil Vij on Sunday informed that the state has received proposal for supply of 60 million doses of COVID vaccine Sputnik V from Pharma Regulatory Services Limited, Malta.

Serbia began production on Friday of Russia's Sputnik V coronavirus vaccine.

Overall, 13.2% of the total Indian population have got at least one dose and 3.3% have got both doses.

Biological E is working with Baylor College of Medicine (BCM) to make Corbevax. It is undergoing Phase 3 trials and has shown promising results in the Phase 1 and 2 trials.